Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) Equity Average: 2011-2024

Historic Equity Average for Cryo Cell International (CCEL) over the last 14 years, with FY2024 value amounting to -$12.1 million.

  • Cryo Cell International's Equity Average fell 4970.94% to -$15.2 million in Q3 2025 from the same period last year, while for Aug 2025 it was -$15.2 million, marking a year-over-year decrease of 4970.94%. This contributed to the annual value of -$12.1 million for FY2024, which is 9312.0% down from last year.
  • Per Cryo Cell International's latest filing, its Equity Average stood at -$12.1 million for FY2024, which was down 9312.0% from -$6.3 million recorded in FY2023.
  • In the past 5 years, Cryo Cell International's Equity Average ranged from a high of $1.3 million in FY2022 and a low of -$12.1 million during FY2024
  • Over the past 5 years, Cryo Cell International's median Equity Average value was -$4.8 million (recorded in 2020), while the average stood at -$4.2 million.
  • Per our database at Business Quant, Cryo Cell International's Equity Average surged by 11579.52% in 2021 and then plummeted by 57201.04% in 2023.
  • Cryo Cell International's Equity Average (Annual) stood at -$4.8 million in 2020, then surged by 115.8% to $759589.5 in 2021, then skyrocketed by 75.1% to $1.3 million in 2022, then plummeted by 572.01% to -$6.3 million in 2023, then tumbled by 93.12% to -$12.1 million in 2024.
  • Its Equity Average was -$12.1 million in FY2024, compared to -$6.3 million in FY2023 and $1.3 million in FY2022.